Most, if not all, pharmaceutical companies today are moving towards a paperless reporting structure. This article examines FDA's 21 CFR Part 11 regulations, which relate to technical and procedural compliance for electronic records and signatures.
Nigel Bowden
Advertisement
Articles by Nigel Bowden
Advertisement
Latest Updated Articles
Paperless Reporting: How to Satisfy FDAPublished: August 1st 2004 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Frankfurt 2025: Regulatory Challenges for Global Manufacturing of Vaccines
2
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
3
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
4
Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One
5
